Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. - Wikidata - awgldk - TriplyDB

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

http://www.wikidata.org/entity/Q36097436

about

De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer Oral cavity and oropharyngeal squamous cell carcinoma--an update The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation Human papilloma virus infection in head and neck cancer Discussing the diagnosis of HPV-OSCC: common questions and answers Human papillomavirus induced transformation in cervical and head and neck cancers Is radiation dose reduction the right answer for HPV-positive head and neck cancer?What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..Management of Oropharyngeal Cancer in the HPV Era.Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign.Clinical features and treatment strategy for HPV-related oropharyngeal cancer.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Counseling the patient with potentially HPV-related newly diagnosed head and neck cancer Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.Surgical margins and primary site resection in achieving local control in oral cancer resections.Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue.Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.Tobacco use and cessation for cancer survivors: an overview for clinicians The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.Deregulation of SYCP2 predicts early stage human papillomavirus-positive oropharyngeal carcinoma: A prospective whole transcriptome analysis The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.

P2860

Q24200362-A9DBD74A-793C-4237-97DC-703BEE65DDF7 Q26739706-B9E786AD-07E9-41FE-ADFE-01C0AAB86523 Q26752584-E1E1030D-D908-47DC-B3FE-178E33B9A161 Q26767046-A2AF7184-D2AD-42DC-AD1C-8DA82BBE28E0 Q26783559-DBBFD98C-B8AD-4E4E-8100-4CBA4526BD72 Q26799210-BEC85C10-42AD-4A3D-9272-379EAB0AC31B Q26830495-4AB0271D-31EB-4A98-9D8E-6DA9BD4F1FB6 Q26849353-F205D3C1-52AB-40E8-9FC6-A4721D942A47 Q26996504-E0DD01C8-CA16-46C1-957F-DA9B098BF0A7 Q27000693-480F0EFB-0E93-4A33-AFE8-526C92911F57 Q27003141-DDBD19E7-018C-47A9-84D9-02A37A77A6A7 Q27024764-041757E6-979F-4320-8C03-A3869CB1AF5B Q27026269-DDB9C296-7587-49C3-8DA3-39FBAD2EB2D3 Q27853302-51CD6B5B-8398-40EC-BB10-3006FD4FCEA3 Q30248326-87C9E6EC-8153-4928-9E2F-7E9190B6A020 Q30248794-02296E14-B922-4016-95EB-CEDC03624487 Q30249150-46BCDE1B-D6C6-436A-B35C-708202B2C3D9 Q30252081-46B35C37-22BB-4DDA-A306-27F00CB5DABB Q30373904-D511FA5D-024A-4DF2-A10A-87A69E0BF7DB Q30650708-CF92E774-C44F-41F9-9650-ADD738A4E3B8 Q33863850-8D27A60B-06CE-4A95-B1AC-5E6937F33B1E Q33908473-E522FB73-321A-4B90-9AD4-10B7A640E26A Q34129454-F4ABD8A3-FA64-4CED-B96A-DE6804E49B2E Q34249991-321D80FF-B5B9-4ACD-B70B-597DE31FD3EF Q34379240-6C997BF8-7864-4675-B738-38DB942C70FC Q34477920-935B1335-C365-4F9F-A37A-8204892BC641 Q34642109-98E41500-01D2-48E2-B49D-80C2F9A44787 Q34659395-EE3CF19F-356D-4F47-B538-4A0B07960627 Q35133434-8D6A9A26-57D1-453A-8825-1087AE9EBA2C Q35226577-175F33B9-5466-45D7-BD49-5EE4D79B6C4F Q35344832-60016015-387C-4F14-9238-AC48793602EC Q35602143-D4D14A68-B288-48DC-8240-5F14D99AFECD Q35669647-801E906D-E5DF-494D-ACDA-1EB8068EF133 Q35678211-03A98FA6-08A6-42AB-9017-C9EDDE6C8048 Q35763033-2993DFE7-A34E-4DE9-B7F3-49D5573790F5 Q35838231-3BFD4CCA-5064-4AEF-BA3F-DF8E931A69F7 Q35861606-C4E4AABD-C03E-4B96-A28B-6A201EEC0EE6 Q35925634-447E9887-2D36-4E92-BEC2-09069DCC04D4 Q35940834-F265807F-BD58-4730-B285-A6553DBC6608 Q35990622-22665ED2-3A01-495A-AC02-A1C5251EEF7E

P2860

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

http://www.wikidata.org/entity/Q36097436

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@ast

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@en

type

label

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@ast

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@en

prefLabel

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@ast

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@en

P1433

Q36097436-33DB30A0-2E21-4A3C-9576-4B217E8E8B09

P1476

Q36097436-F656521F-652D-4BC4-92D6-E2CEA657A2B6

P2093

Q36097436-00CAF4E7-9B20-4C26-B41C-75EEBC30170E

Q36097436-1DC57E53-9DA4-4395-BA23-C97398DE5249

Q36097436-59B1C170-324D-42A9-80CB-AF383CCF6CD0

Q36097436-8DE2B1BB-D61C-4EE8-9C3C-D3E19199B9C7

Q36097436-92BE1FF9-6EE6-4009-B4E9-49DE6CAE1AAB

Q36097436-AF25EE7D-65DD-4165-94C9-1B88C9902DF8

Q36097436-D91E31AC-736D-4094-A3C3-446FCE411C78

Q36097436-E2C752E9-E734-4B2D-B851-CCDF107C8F84

Q36097436-EEB639FF-A466-4789-83AE-09A95A25C755

Q36097436-EF726A52-8DD5-4A30-BE89-BCABCD6DD314

P2860

Q36097436-01DBBD6C-38CF-455C-AD8F-8D970E538CB7

Q36097436-0A6240D7-CD55-4ACF-8A7A-0678F2E75CB9

Q36097436-0D715D0D-8294-41CB-82BC-1E9483FA3DAA

Q36097436-0F1B3800-B337-48A5-A91A-4F3CF180CFC6

Q36097436-11677051-398C-4C99-8EBB-EB359B4104B4

Q36097436-1B5E4F7F-5A23-41CC-A5A6-641BC9D97C2A

Q36097436-1DF83497-8A1E-401C-9941-F363EB04F012

Q36097436-3B9BAB51-FFDE-41A9-B160-5FAB09CCCEBC

Q36097436-49D8F3E9-52A8-4007-9A0B-A5FC28F66782

Q36097436-5E575112-7476-4ADA-B203-7F340DCA11D0

P304

Q36097436-139FD7BE-D2ED-4F4C-ADBD-D71C19651E00

P31

Q36097436-70F783E0-5D15-4777-B051-09B5D68FB4BF

P356

Q36097436-00E87A81-DB5D-481D-9152-00AD7B9505BB

P407

Q36097436-998EDF99-40C1-4EE6-BA67-05DFD07C2B07

P433

Q36097436-43C0D3C7-C37A-414A-AA86-3B765F958490

P478

Q36097436-57FB7E12-3078-4F13-811A-BBDA8BAF6563

P577

Q36097436-F91CC4AE-17CA-464C-BD72-2D14DA45116A

P698

Q36097436-6378BF57-A6FF-40CE-9E91-A2D3B7DABE2F

P932

Q36097436-CD8D4BC5-6DF6-4CC4-B050-D4134453C5DC

P356

JCO.2011.38.4099

P1433

Journal of Clinical Oncology

P1476

Tobacco smoking and increased ...... negative oropharyngeal cancer.

@en

P2093

Andy Trotti

http://www.w3.org/2001/XMLSchema#string

Christine H Chung

http://www.w3.org/2001/XMLSchema#string

Jonathan Harris

http://www.w3.org/2001/XMLSchema#string

K Kian Ang

http://www.w3.org/2001/XMLSchema#string

Maura L Gillison

http://www.w3.org/2001/XMLSchema#string

Qiang Zhang

http://www.w3.org/2001/XMLSchema#string

Richard Jordan

http://www.w3.org/2001/XMLSchema#string

Sharon Spencer

http://www.w3.org/2001/XMLSchema#string

Weihong Xiao

http://www.w3.org/2001/XMLSchema#string

William H Westra

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

Mortality in relation to smoking: 50 years' observations on male British doctors

Human papillomavirus and survival of patients with oropharyngeal cancer.

Case-control study of human papillomavirus and oropharyngeal cancer

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Mortality from cancer in relation to smoking: 50 years observations on British doctors.

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

P304

2102-2111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.38.4099

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22565003

http://www.w3.org/2001/XMLSchema#string

P932

3397696

http://www.w3.org/2001/XMLSchema#string